Study of Aripiprazole to Treat Children and Adolescents With Autism

Clinical trial NCT00619190 · COMPLETED

Trial details

NCT number: NCT00619190
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autistic Disorder Asperger Syndrome Autism Spectrum Disorder

Start date: 2006-01-01
Primary completion: 2012-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.